Nuffield Division of Clinical Laboratory Sciences
Head of Division
About NDCLS
Our aim is to study the pathology of human disease from the molecular to systems level, and to translate our findings into treatments for human disorders.
Read moreLatest publications
-
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.
Journal article
Rahman S. et al, (2024), Blood
-
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
Journal article
DAVIES J., (2024), Nature Reviews Drug Discovery
-
A developmental route to hematopoietic stem cells.
Journal article
Wilkinson AC. and de Bruijn MFTR., (2024), Nat Biotechnol
-
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer.
Journal article
Nowak M. et al, (2024), Cell Rep Med, 5
The Latest News
Grant awarded to develop artificial intelligence tools to understand the bone marrow landscape
14 August 2024
Our researchers have received $200,000 to develop artificial intelligence tools to better diagnose what goes wrong in the bone marrow of myeloproliferative neoplasm (MPN) patients.
Experts outline priority areas which should be addressed to advance treatment for inherited lung diseases
29 July 2024
An expert group including Deborah Gill, Professor of Gene Medicine in RDM’s Nuffield Division of Clinical Laboratory Sciences, has published a new position paper which addresses the gaps in research and treatment development for familial pulmonary fibrosis (FPF) – a collection of individually rare and severe genetically inherited lung diseases.
New Oxford–BMS Translational Fellowships announced
13 September 2023
Two new Oxford–Bristol Myers Squibb Fellowships will support postdoctoral researchers and clinicians in the Radcliffe Department of Medicine.